Side-by-side comparison of AI visibility scores, market position, and capabilities
Copenhagen container shipping and integrated logistics (Nasdaq CPH: MAERSK-B) at $55.5B 2024 revenue; +56% net profit to $6.09B from Red Sea disruption with 2025 EBITDA guidance $9-9.5B competing with MSC for global logistics.
A.P. Møller - Mærsk A/S is a Copenhagen, Denmark-based integrated container logistics company — listed on Nasdaq Copenhagen (MAERSK-A, MAERSK-B) — operating as the world's second-largest container shipping company with a fleet serving 374 ports in 116 countries, and an end-to-end logistics provider offering ocean freight, port terminals, land transport, warehousing, air freight, and customs brokerage. In 2024, Maersk reported $55.5 billion in revenue and net profit of $6.09 billion (+56% from 2023), benefiting from Red Sea disruption-driven rate increases (+38.1% container rates) that routed vessels around the Cape of Good Hope, extending voyage times and tightening global capacity. For 2025, Maersk raised its guidance to underlying EBITDA of $9.0-9.5 billion and EBIT of $3.0-3.5 billion. Maersk employs 100,000+ people across 130 countries. Founded 1904 by Arnold Peter Møller and Peter Mærsk Møller; net-zero emissions target by 2040.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.